Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Feb;63(2):200–205. doi: 10.1136/ard.2003.007674

Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein

T Sturmer 1, H Brenner 1, W Koenig 1, K Gunther 1
PMCID: PMC1754873  PMID: 14722211

Abstract

Background: Although osteoarthritis (OA) is thought to derive from defective chondrocyte metabolism and thus inherently lack the large scale systemic response of rheumatoid arthritis, there is increasing interest in the acute phase proteins in OA.

Objective: To assess the association between high sensitivity C reactive protein (hsCRP) and severity and extent of OA in patients with advanced hip and knee OA.

Methods: Preoperative hsCRP was measured in frozen serum samples from 770 consecutive patients with hip or knee joint replacement due to advanced OA recruited between 1995 and 1996. Pain was measured by a visual analogue scale and the Western Ontario and McMaster Universities OA index (WOMAC). The extent of OA in different joints was assessed clinically and radiographically.

Results: The (geometric) mean hsCRP was 2.5 mg/l among all patients. Severity of pain was associated with mean hsCRP (adjusted elevation highest v lowest quintile = 35%, p = 0.01) after controlling for known or suspected predictors of hsCRP, including age, smoking, and body mass index. Neither the bilateral nor the generalised extent of OA, nor any of the dimensions of the WOMAC were associated with mean hsCRP levels.

Conclusions: Severity of pain, but not extent of OA, was associated with hsCRP levels in this group of patients with advanced OA. Longitudinal studies with repeated assessments of hsCRP and pain are needed to assess the possible value of hsCRP for monitoring or predicting the clinical course of OA.

Full Text

The Full Text of this article is available as a PDF (274.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman R. D., Hochberg M., Murphy W. A., Jr, Wolfe F., Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage. 1995 Sep;3 (Suppl A):3–70. [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Bellamy N., Kean W. F., Buchanan W. W., Gerecz-Simon E., Campbell J. Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol. 1992 Jan;19(1):153–159. [PubMed] [Google Scholar]
  4. Conrozier T., Chappuis-Cellier C., Richard M., Mathieu P., Richard S., Vignon E. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Rev Rhum Engl Ed. 1998 Dec;65(12):759–765. [PubMed] [Google Scholar]
  5. Creamer P., Hochberg M. C. Why does osteoarthritis of the knee hurt--sometimes? Br J Rheumatol. 1997 Jul;36(7):726–728. doi: 10.1093/rheumatology/36.7.726. [DOI] [PubMed] [Google Scholar]
  6. Creamer P., Lethbridge-Cejku M., Hochberg M. C. Determinants of pain severity in knee osteoarthritis: effect of demographic and psychosocial variables using 3 pain measures. J Rheumatol. 1999 Aug;26(8):1785–1792. [PubMed] [Google Scholar]
  7. Fröhlich M., Imhof A., Berg G., Hutchinson W. L., Pepys M. B., Boeing H., Muche R., Brenner H., Koenig W. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000 Dec;23(12):1835–1839. doi: 10.2337/diacare.23.12.1835. [DOI] [PubMed] [Google Scholar]
  8. Günther K. P., Scharf H. P., Puhl W., Willauschus W., Kalke Y., Glückert K., Sun Y. Reproduzierbarkeit der radiologischen Diagnostik bei Gonarthrose. Z Orthop Ihre Grenzgeb. 1997 May-Jun;135(3):197–202. doi: 10.1055/s-2008-1039580. [DOI] [PubMed] [Google Scholar]
  9. Günther K. P., Scharf H. P., Puhl W., Willauschus W., Sauerland S., Glückert K., Sun Y. Reproduzierbarkeit der röntgenologischen Beurteilung von Coxarthrosen. Z Orthop Ihre Grenzgeb. 1997 Jan-Feb;135(1):3–8. doi: 10.1055/s-2008-1039547. [DOI] [PubMed] [Google Scholar]
  10. Günther K. P., Stürmer T., Sauerland S., Zeissig I., Sun Y., Kessler S., Scharf H. P., Brenner H., Puhl W. Prevalence of generalised osteoarthritis in patients with advanced hip and knee osteoarthritis: the Ulm Osteoarthritis Study. Ann Rheum Dis. 1998 Dec;57(12):717–723. doi: 10.1136/ard.57.12.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Herold M., Günther R. Circadian rhythm of C-reactive protein in patients with rheumatoid arthritis. Prog Clin Biol Res. 1987;227B:271–279. [PubMed] [Google Scholar]
  12. Imhof A., Froehlich M., Brenner H., Boeing H., Pepys M. B., Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001 Mar 10;357(9258):763–767. doi: 10.1016/S0140-6736(00)04170-2. [DOI] [PubMed] [Google Scholar]
  13. KELLGREN J. H., LAWRENCE J. S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957 Dec;16(4):494–502. doi: 10.1136/ard.16.4.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Katz J., Melzack R. Measurement of pain. Surg Clin North Am. 1999 Apr;79(2):231–252. doi: 10.1016/s0039-6109(05)70381-9. [DOI] [PubMed] [Google Scholar]
  15. Kessler S., Dieppe P., Fuchs J., Stürmer T., Günther K. P. Assessing the prevalence of hand osteoarthritis in epidemiological studies. The reliability of a radiological hand scale. Ann Rheum Dis. 2000 Apr;59(4):289–292. doi: 10.1136/ard.59.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kidd B. L., Urban L. A. Mechanisms of inflammatory pain. Br J Anaesth. 2001 Jul;87(1):3–11. doi: 10.1093/bja/87.1.3. [DOI] [PubMed] [Google Scholar]
  17. Kumon Y., Suehiro T., Nishiya K., Hashimoto K., Nakatani K., Sipe J. D. Ferritin correlates with C-reactive protein and acute phase serum amyloid A in synovial fluid, but not in serum. Amyloid. 1999 Jun;6(2):130–135. doi: 10.3109/13506129909007314. [DOI] [PubMed] [Google Scholar]
  18. Martelletti P. Proinflammatory pathways in cervicogenic headache. Clin Exp Rheumatol. 2000 Mar-Apr;18(2 Suppl 19):S33–S38. [PubMed] [Google Scholar]
  19. Meier-Ewert H. K., Ridker P. M., Rifai N., Price N., Dinges D. F., Mullington J. M. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem. 2001 Mar;47(3):426–430. [PubMed] [Google Scholar]
  20. Merritt J. L. Soft tissue mechanisms of pain in osteoarthritis. Semin Arthritis Rheum. 1989 May;18(4 Suppl 2):51–56. doi: 10.1016/0049-0172(89)90016-4. [DOI] [PubMed] [Google Scholar]
  21. Paul-Dauphin A., Guillemin F., Virion J. M., Briançon S. Bias and precision in visual analogue scales: a randomized controlled trial. Am J Epidemiol. 1999 Nov 15;150(10):1117–1127. doi: 10.1093/oxfordjournals.aje.a009937. [DOI] [PubMed] [Google Scholar]
  22. Ridker P. M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001 Apr 3;103(13):1813–1818. doi: 10.1161/01.cir.103.13.1813. [DOI] [PubMed] [Google Scholar]
  23. Schumacher R., Jr The role of inflammation and crystals in the pain of osteoarthritis. Semin Arthritis Rheum. 1989 May;18(4 Suppl 2):81–85. doi: 10.1016/0049-0172(89)90022-x. [DOI] [PubMed] [Google Scholar]
  24. Sharif M., Elson C. J., Dieppe P. A., Kirwan J. R. Elevated serum C-reactive protein levels in osteoarthritis. Br J Rheumatol. 1997 Jan;36(1):140–141. doi: 10.1093/rheumatology/36.1.140. [DOI] [PubMed] [Google Scholar]
  25. Spector T. D., Hart D. J., Nandra D., Doyle D. V., Mackillop N., Gallimore J. R., Pepys M. B. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997 Apr;40(4):723–727. doi: 10.1002/art.1780400419. [DOI] [PubMed] [Google Scholar]
  26. Stürmer T., Erb A., Keller F., Günther K. P., Brenner H. Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half-life and other medications. Am J Med. 2001 Nov;111(7):521–527. doi: 10.1016/s0002-9343(01)00942-1. [DOI] [PubMed] [Google Scholar]
  27. Sun Y., Stürmer T., Günther K. P., Brenner H. Inzidenz und Prävalenz der Cox- und Gonarthrose in der Allgemeinbevölkerung. Z Orthop Ihre Grenzgeb. 1997 May-Jun;135(3):184–192. doi: 10.1055/s-2008-1039578. [DOI] [PubMed] [Google Scholar]
  28. Wigler I., Neumann L., Yaron M. Validation study of a Hebrew version of WOMAC in patients with osteoarthritis of the knee. Clin Rheumatol. 1999;18(5):402–405. doi: 10.1007/s100670050126. [DOI] [PubMed] [Google Scholar]
  29. Wolfe F. Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford) 1999 Apr;38(4):355–361. doi: 10.1093/rheumatology/38.4.355. [DOI] [PubMed] [Google Scholar]
  30. Wolfe F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol. 1997 Aug;24(8):1486–1488. [PubMed] [Google Scholar]
  31. Woolf C. J., Decosterd I. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain. 1999 Aug;Suppl 6:S141–S147. doi: 10.1016/S0304-3959(99)00148-7. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES